Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)
CompletedOBSERVATIONAL
Enrollment
286
Participants
Timeline
Start Date
April 8, 2015
Primary Completion Date
June 5, 2019
Study Completion Date
June 5, 2019
Conditions
Anomalies in Glucose MetabolismCoronary Artery Bypass Graft
Interventions
OTHER
Collection of biological data
OTHER
Collection of clinical data
Trial Locations (1)
21079
CHU Dijon Bourgogne, Dijon
All Listed Sponsors
lead
Centre Hospitalier Universitaire Dijon
OTHER
NCT02855879 - Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG) | Biotech Hunter | Biotech Hunter